1. Home
  2. ACAD vs MCHB Comparison

ACAD vs MCHB Comparison

Compare ACAD & MCHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$21.84

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

MCHB

Mechanics Bancorp

HOLD

Current Price

$15.05

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACAD
MCHB
Founded
1993
1905
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.1B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
ACAD
MCHB
Price
$21.84
$15.05
Analyst Decision
Buy
Buy
Analyst Count
22
2
Target Price
$30.55
$15.75
AVG Volume (30 Days)
1.3M
390.4K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
5.53%
EPS Growth
69.12
N/A
EPS
0.02
N/A
Revenue
$726,437,000.00
N/A
Revenue This Year
$18.80
$43.32
Revenue Next Year
$11.70
N/A
P/E Ratio
$1,085.00
$12.70
Revenue Growth
40.45
N/A
52 Week Low
$19.69
$12.82
52 Week High
$28.35
$16.03

Technical Indicators

Market Signals
Indicator
ACAD
MCHB
Relative Strength Index (RSI) 51.39 54.89
Support Level $21.04 $13.90
Resistance Level $22.03 $15.73
Average True Range (ATR) 0.58 0.37
MACD 0.07 0.08
Stochastic Oscillator 79.63 71.72

Price Performance

Historical Comparison
ACAD
MCHB

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.

About MCHB Mechanics Bancorp

Mechanics Bancorp is an independent, full-service community bank. It provides personal banking, business banking, trust and estate, brokerage and wealth management services. its retail banking products include personal checking, savings, and loan products (including credit card, home equity, home mortgage, and secured/unsecured loans), online banking, and wealth management services (including trust and estate, investment management, and financial planning services). its banking products and services for businesses include business checking and savings accounts, business debit cards, online banking, cash management services, wealth management services, business credit cards, commercial real estate loans, equipment leasing, and loans guaranteed by the Small Business Administration.

Share on Social Networks: